Light Treatment Effectiveness (LITE) Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Psoriasis
- Psoriatic Plaque
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Pragmatic, randomized, active comparator effectiveness studyMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 12 years and 125 years
- Gender
- Both males and females
Description
The primary objective of this study is to compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis. Physician Global Assessment (PGA) and Dermatology Life Quality ...
The primary objective of this study is to compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis. Physician Global Assessment (PGA) and Dermatology Life Quality Index (DLQI) will be used to assess effectiveness, safety (tolerability), and duration of treatment response. This is a three year pragmatic, randomized, active comparator effectiveness study.
Tracking Information
- NCT #
- NCT03726489
- Collaborators
- University of Utah
- National Psoriasis Foundation
- Patient-Centered Outcomes Research Institute
- Investigators
- Principal Investigator: Joel M. Gelfand, MD,MSCE University of Pennsylvania
Get Well Soon